No Data
No Data
Piper Sandler Maintains Context Therapeutics(CNTX.US) With Buy Rating, Maintains Target Price $4.5
Context Therapeutics Bolsters Board With Industry Veterans
Express News | Context Therapeutics: Board Increased Its Size From Five Members to Seven Members
Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors
Express News | Context Therapeutics Appoints DR. Karen Smith and DR. Luke Walker to Board of Directors
Press Release: Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors
No Data
No Data